Literature DB >> 12424551

Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder.

Adam R Clarke1, Robert J Barry, Dominique Bond, Rory McCarthy, Mark Selikowitz.   

Abstract

RATIONALE: Stimulant medications are the most commonly used treatments for attention deficit/hyperactivity disorder (ADHD) in North America and Australia, although it is still not entirely known how these medications work.
OBJECTIVES: This study aimed to investigate the effects of stimulant medications on the EEG of children with the Combined subtype of ADHD.
METHOD: An initial EEG was recorded during an eyes-closed resting condition and Fourier transformed to provide absolute and relative power estimates for the delta, theta, alpha and beta bands. Theta/alpha and theta/beta ratios were also calculated. Subjects were placed on a 6-month trial of a stimulant and a second EEG was recorded at the end of the trial.
RESULTS: The ADHD group had significantly greater absolute delta and theta, less posterior absolute beta, more relative theta, and less relative alpha than the control group, which is typical of EEG studies of children with ADHD. The use of stimulant medications resulted in normalisation of the EEG, primarily evident in changes in the theta and beta bands.
CONCLUSIONS: These results suggest that stimulants act to increase cortical arousal in children with ADHD, normalising their brain activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424551     DOI: 10.1007/s00213-002-1205-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

Review 1.  Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.

Authors:  M Tan; R Appleton
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

2.  GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.

Authors:  Hyejung Won; Won Mah; Eunjin Kim; Jae-Won Kim; Eun-Kyoung Hahm; Myoung-Hwan Kim; Sukhee Cho; Jeongjin Kim; Hyeran Jang; Soo-Churl Cho; Boong-Nyun Kim; Min-Sup Shin; Jinsoo Seo; Jaeseung Jeong; Se-Young Choi; Daesoo Kim; Changwon Kang; Eunjoon Kim
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

3.  Performance on the continuous performance test in children with ADHD is associated with sleep efficiency.

Authors:  Reut Gruber; Natalie Grizenko; George Schwartz; Johanne Bellingham; Rosherrie Guzman; Ridha Joober
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

4.  Sex differences in the pathway from low birth weight to inattention/hyperactivity.

Authors:  Michelle M Martel; Victoria C Lucia; Joel T Nigg; Naomi Breslau
Journal:  J Abnorm Child Psychol       Date:  2006-12-20

5.  Attention deficit hyperactivity disorder (ADHD) in children with epilepsy.

Authors:  Man Wang; Qin Zhao; Huicong Kang; Suiqiang Zhu
Journal:  Ir J Med Sci       Date:  2019-06-11       Impact factor: 1.568

Review 6.  Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action.

Authors:  Steven R Pliszka
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

7.  Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.

Authors:  David E Evans; Steven K Sutton; Jason A Oliver; David J Drobes
Journal:  Psychopharmacology (Berl)       Date:  2014-12-10       Impact factor: 4.530

8.  Estimating the passage of minutes: deviant oscillatory frontal activity in medicated and unmedicated ADHD.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Matthew L White; Nichole L Knott; Martin W Wetzel
Journal:  Neuropsychology       Date:  2013-09-16       Impact factor: 3.295

9.  Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.

Authors:  Sandra K Loo; Robert M Bilder; Alexander L Cho; Alexandra Sturm; Jennifer Cowen; Patricia Walshaw; Jennifer Levitt; Melissa Del'Homme; John Piacentini; James J McGough; James T McCracken
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-05-21       Impact factor: 8.829

10.  Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.

Authors:  D E Evans; S K Sutton; K G Jentink; H-Y Lin; J Y Park; D J Drobes
Journal:  Genes Brain Behav       Date:  2016-09       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.